|
Market Closed -
Nasdaq
04:00:00 2026-09-11 pm EDT
|
5-day change | 1st Jan Change | ||
| 8.030 USD | -1.47% |
|
+0.12% | +20.07% |
| Aug. 11 | Harvard Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Aug. 11 | Harvard Bioscience, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
| Market Cap | 36.56M 31.5M 29.82M 27.03M 50.71M 3.49B 50.97M 354M 136M 1.78B 137M 134M 5.61B | P/E 2026 * |
-4.13x | P/E 2027 * | -17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 36.56M 31.5M 29.82M 27.03M 50.71M 3.49B 50.97M 354M 136M 1.78B 137M 134M 5.61B | EV / Sales 2026 * |
0.41x | EV / Sales 2027 * | 0.39x |
| Free-Float |
90.61% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| HBIO | Delayed | |
CBOE
| HBIO | Real-time |
Last Transcript : Harvard Bioscience, Inc.
| 1 day | -1.47% | ||
| 1 week | +0.12% | ||
| Current month | -0.99% | ||
| 1 month | +31.00% | ||
| 3 months | +20.93% | ||
| 6 months | +58.35% | ||
| Current year | +20.07% |
| 1 week | 7.85 |  | 8.18 |
| 1 month | 6.08 | | 8.4 |
| Current year | 4 | | 8.4 |
| 1 year | 3.76 | | 9.4 |
| 3 years | 2.81 | | 55.6 |
| 5 years | 2.81 | | 82.3 |
| 10 years | 2.81 | | 87.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Duke
CEO | Chief Executive Officer | 55 | 2025-07-27 |
Mark Frost
DFI | Director of Finance/CFO | 63 | 2025-05-11 |
Diane Houston
CTO | Chief Tech/Sci/R&D Officer | - | 2019-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Katherine Eade
BRD | Director/Board Member | 52 | 2017-10-23 |
John Duke
BRD | Director/Board Member | 55 | 2025-06-01 |
Robert Gagnon
BRD | Director/Board Member | 52 | 2025-07-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/20/26 | Free | Chief Executive Officer | 75,000 | 0.1677% | ||
| 3/20/26 | Free | Chief Financial Officer | 30,000 | 0.0671% | ||
| 3/17/26 | Buy | Director | 10,000 | 0.0224% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.47% | +0.12% | +81.06% | -80.70% | 36.51M | |
| +1.10% | -0.65% | +24.10% | +18.43% | 225B | |
| -0.19% | -3.62% | +2.55% | -20.00% | 141B | |
| +2.41% | +0.67% | -19.02% | +22.09% | 130B | |
| -0.28% | -10.08% | -58.81% | -21.22% | 62.29B | |
| -2.77% | -6.15% | +8.15% | +12.69% | 48.63B | |
| -0.49% | -1.97% | -20.35% | -15.53% | 49.39B | |
| +2.66% | -2.61% | +15.94% | +29.91% | 41.42B | |
| +1.67% | -0.25% | +35.01% | +55.09% | 40.12B | |
| -0.60% | -4.41% | -20.52% | +44.06% | 31.23B | |
| Average | +0.21% | -3.07% | +4.81% | +4.48% | 76.97B | |
| Weighted average by Cap. | +0.52% | -2.50% | +0.61% | +9.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 89.8M 77.37M 73.26M 66.4M 125M 8.58B 125M 870M 335M 4.36B 337M 330M 13.79B | 94.55M 81.46M 77.14M 69.92M 131M 9.03B 132M 916M 352M 4.6B 355M 347M 14.52B |
| Net income | -8.9M -7.67M -7.26M -6.58M -12.35M -850M -12.41M -86.24M -33.16M -433M -33.42M -32.69M -1.37B | -2.2M -1.9M -1.79M -1.63M -3.05M -210M -3.07M -21.32M -8.2M -107M -8.26M -8.08M -338M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | $8.030 | -1.47% | 8,346 |
| 26-09-10 | $8.150 | +2.52% | 15,710 |
| 26-09-09 | $7.950 | 0.00% | 9,094 |
| 26-09-08 | $7.950 | -0.87% | 12,314 |
| 26-09-04 | $8.020 | +0.25% | 9,893 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HBIO Stock
Select your edition
All financial news and data tailored to specific country editions
